DarshanTalks Podcast

406 Folgen

1. Anti-Kickback Settlement Surge

   Vom: 20.8.2019
2. Insys & Mallinckrodt: Is Legal Really Necessary on Your Promotional Review Teams?

   Vom: 15.8.2019
3. Alzheimer’s and Snake Oil Salesmen

   Vom: 13.8.2019
4. Stem Cell Clinics

   Vom: 13.8.2019
5. Responding to an FDA Inspection – Part 3 (Preparing a War Room)

   Vom: 8.8.2019
6. Responding to an FDA Inspection – Part 4 (Preparing a War Room)

   Vom: 8.8.2019
7. Responding to an FDA Inspection – Part 2 (FDA Findings, What the FDA Can Do)

   Vom: 8.8.2019
8. Responding to an FDA Inspection – Part 1 (FDA Findings, What the FDA Can Do)

   Vom: 8.8.2019
9. Diving Deeper Into Understanding Bioethics

   Vom: 8.8.2019
10. 10 Ways to Communicate With the FDA

    Vom: 1.8.2019
11. FDA and Vaping: Influencer Marketing Warning

    Vom: 23.7.2019
12. Types of Ethics

    Vom: 20.7.2019
13. ENDS Product Marketing: FDA releases guidance on marketing vaping products

    Vom: 16.7.2019
14. 23&me and Ethical Engagement

    Vom: 11.7.2019
15. FDA Warning Letter: Vivus

    Vom: 11.7.2019
16. Government Shutdowns & Patient Centricity

    Vom: 6.6.2019
17. CBD: FDA Hearing

    Vom: 31.5.2019
18. Minimizing Participant Loss in Clinical Trials – Part 2

    Vom: 30.5.2019
19. Minimizing Participant Loss in Clinical Trials – Part 1

    Vom: 23.5.2019
20. Why Patients Aren’t Joining Your Clinical Trial – Part 2

    Vom: 16.5.2019